2020 American Transplant Congress Archives - Page 205 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

4:15pm-4:27pm: Absence of Adverse Infectious Disease Outcomes in the Long-Term Follow-Up of Recipients of PHS Increased Risk Donor Organs: An Essential Tracking Program

L. Irwin, J. Fishman

Quality Assurance Process Improvement & Regulatory Issues II • Virtual

4:15pm-4:27pm: Activated CD27⁺CD21^– Subset Dominate the Memory B Cell Response During Antibody-Mediated Rejection of Kidney Allografts

K. Louis¹, E. Bailly¹, C. Macedo¹, M. Marrari¹, M. Yamada¹, P. Randhawa¹, A. Zeevi¹, C. Lefaucheur², D. Metes¹

Kidney Acute Antibody Mediated Rejection • Virtual

4:15pm-4:27pm: Age-Enhanced Transplant Vasculopathy Associates with Impaired Vascular Mitophagy

M. Blin¹, D. Tyrrell¹, S. Wood¹, D. Farris¹, S. G. Tullius², D. R. Goldstein¹

Endothelial Cell Biology • Virtual

4:15pm-4:27pm: Apoptotic Exosome-Like Vesicles are Associated with Alloimmune Vascular Injury in Kidney Transplant Recipients

M. Dieude¹, E. Boilard², I. Allaeys², A. Deneault-Marchand¹, J. Turgeon¹, E. Dore², S. Lariviere-Beaudoin¹, A. Karakeussian-Rimbaud¹, S. Collette³, L. Senecal³, M. Hebert¹, H. Cardinal¹

Biomarkers, Immune Assessment and Clinical Outcomes V • Virtual

4:15pm-4:27pm: Association between Mycoplasma and Ureaplasma Airway Colonization, Ammonia Levels and Outcomes Post Lung Transplantation

B. Buzo¹, J. Preiksaitis¹, K. Halloran², J. Nagendran³, D. Townsend⁴, N. Zelyas⁵, W. Sligl⁴

Donor Derived Infections • Virtual

4:15pm-4:27pm: Belatacept Conversion: Are Patients BENEFIT-ing

R. Crew, S. Mohan, S. S. Patel

Novel Immunosuppression: Belatacept • Virtual

4:15pm-4:27pm: Belatacept Every Two Month Maintenance Dosing in Kidney Transplantation: A Randomized, Non-Inferiority Trial

I. R. Badell, R. Parsons, S. Mead, S. Thomas, G. Karadkhele, S. Pastan, C. Larsen

Immunosuppressive Drug Minimization • Virtual

4:15pm-4:27pm: Benefits of Normothermia Regional Perfusion (NRP), Hypothermic Machine Perfusion (HMP) and Short Cold Ischemia Time (CIT) for Kidney Transplants with Controlled Donation after Circulatory Death (cDCD)

E. Savoye¹, C. Legeai¹, J. Branchereau², S. Gay³, S. Drouin⁴, F. Gaudez⁵, B. Veber⁶, J. Venhard⁷, G. Cheisson⁸, T. Kerforne⁹, O. Bastien¹, C. Antoine¹

Kidney Deceased Donor Selection II • Virtual

4:15pm-4:27pm: Biliary Reconstructionwith High Biliary Radicals is Safe Option for Multiple Graft Bile Ducts in Right Lobe Living Donor Liver Transplantation

J. Kim, D. Choi, E. Jwa

Liver: Living Donors and Partial Grafts II • Virtual

4:15pm-4:27pm: Changes in Health-Related Quality of Life During the First Year in Lung Transplantation Recipients

H. Zhou, J. Chen

Living in the Real World: Decision Making and Outcomes After Lung Transplant • Virtual